A new study, entitled “TandemHeart to Reduce Infarct Size” (TRIS) will determine effect of ventricular unloading on myocardial salvage after acute myocardial infarction.
Previously Ascendx Spine only had FDA clearance for its vertebral body excision device. Now it’s all systems go for commercialisation, as the rest of the system gets the nod.
Expanding Orthopedics Inc. has passed the 1,000th XPED Expanding Pedicle Screw™ milestone at the prestigious and historical Rizzoli Institute in Bologna, Italy. The device, is a uniquely expandable pedicle screw designed to offer enhanced anchoring in compromised bone.
Published data demonstrate the Symplicity™ renal denervation system provides blood pressure reduction in patients with treatment-resistant hypertension sustained to 12 months
A new liposuction cannula that avoids the traumatic sawing action employed during fact removal seems like a good idea. Now it’s gained FDA clearance.
MIS spine company SI-BONE, Inc. has seen the first peer-reviewed publication of clinical study results using its iFuse minimally invasive sacroiliac joint fusion device. At the same time the company has announced that it has reached the 5000 patient landmark.
BioVentrix has received CE marking for its clever Revivent™ Myocardial Anchoring System, which makes possible Less Invasive Ventricular Enhancement™ (LIVE™), a procedure that restores the left ventricle from damage done by a heart attack to what the company calls a “more optimal” volume and conical shape.
St. Jude Medical, Inc. has announced the first patient implant of its 23 mm Portico™ Transcatheter Aortic Heart Valve using the Transapical Delivery System.
CardioKinetix’s Parachute ventricular partitioning device has had its CE mark extended to include a full range of sizes, opening up percutaneous ventricular restoration therapy to a wider range of patient anatomies.
The theory is based on sound principles. Insert a coronary stent that is able to expand to adapt to changing vessel size and it will be more effective as the vessel dilates and clot dissolves. Now FDA’s approval of an IDE study will allow Stentys to back its claims.
San Francisco sportsmed surgeon Kevin Stone’s eponymous Stone Clinic has formally introduced BioKnee: A natural knee cartilage reconstruction solution clinically-proven to delay the effects of arthritis for up to 12 years.
Insightra Medical has announced that its new Freedom inguinal hernia system has been cleared by the FDA. The device aims to address post-op chronic pain associated with traditional meshes by avoiding rigid fixation.
Voiding dysfunction device company Uroplasty Inc. tells us that positive results from a long-term clinical pilot study using an implantable tibial nerve stimulation device will be presented at the Annual Meeting of the International Continence Society.
Spinal device company Baxano sees its minimally invasive spinal fusion technology platform expand with the FDA’s clearance of its iO-Tome™ instrument for precise facet joint removal.
ClearPoint Case Performed in Grenoble, France, the Birthplace of Deep Brain Stimulation Therapy
Congenital heart surgeon James Hammel, M.D., on Thursday presented a video demonstration of a novel infant cardiac surgical technique at the joint meeting of the Congenital Heart Surgeons’ Society and the European Congenital Heart Surgeons Association in Chicago. The technique allows many complex heart defect repairs, including the Norwood operation for hypoplastic left heart syndrome, to be performed more quickly and safely.